Transamerica Financial Advisors, LLC
Position in RPRX — Royalty Pharma plc
CIK 1502149
CEDAR RAPIDS, IA
Position in RPRX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$357,726
+$65,397 QoQ
Shares Held
6,380
+4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#438
of 646 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $10,594,247 across 53 Biotechnology names. RPRX ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
77,403 | $6,309,118 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,288 | $2,494,936 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,016 | $504,677 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
6,380 | $357,726 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,673 | $254,257 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
1,789 | $155,553 | |
| 7 | ARGX |
Argenx SE
|
161 | $149,370 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
4,118 | $104,185 |
All Filings in RPRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $357,726 | 6,380 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $292,329 | 6,094 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $199,305 | 5,158 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $164,404 | 4,660 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $612 | 17 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,702 | 1,436 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,285 | 1,932 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $97,855 | 3,459 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $45,620 | 1,730 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $52,540 | 1,730 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $234,916 | 8,363 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $287,602 | 10,597 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $369,709 | 12,027 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $541,062 | 15,017 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $469,102 | 11,870 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $468,780 | 11,667 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $542,904 | 12,914 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||